Qiyu Li

机构：Shenyang Pharmaceutical University, Xi'an University of Architecture and Technology, Guizhou Normal University, South China Normal University, Chinese Academy of Sciences, Institute of Geographic Sciences and Natural Resources Research, University of Chinese Academy of Sciences, Chongqing University of Technology, China Medical University · ORCID：0000-0002-7635-2489

发表论文 80 篇 · 总被引 1893 次 · h-index 23

代表论文

• Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials (2025 · The Lancet · 被引 38)
• Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer (2024 · Journal of Nanobiotechnology · 被引 22)
• Two-dimensional alkali auride bimetallene semiconductors for activating photocatalytic water splitting: Synergistic interaction of electronegativity difference and carrier mobility (2025 · Journal of Colloid and Interface Science · 被引 5)
• Monitoring and numerical analysis of slope deformation in a coal mine in the southwest mountainous regions of China (2024 · Natural Hazards · 被引 5)
• Small nucleic acid therapeutics: delivery breakthroughs, clinical translation, and future paradigms in precision medicine (2025 · International Journal of Pharmaceutics · 被引 4)
• Engineered macrophage membrane fusion liposomes carrying siRNA for spatiotemporal regulation of the CCL2/CCR2 axis for cardiac repair (2025 · Chinese Chemical Letters · 被引 4)